Thema
Journal Article
31
Research Support, Non-U.S. Gov't
12
Multiple sclerosis
11
multiple sclerosis
8
Systematic Review
7
ofatumumab
7
Fingolimod Hydrochloride
6
G926EC510T
6
Immunosuppressive Agents
6
Meta-Analysis
6
Natalizumab
6
disease-modifying therapy
6
indirect treatment comparison
6
network meta-analysis
6
relapsing multiple sclerosis
6
Alemtuzumab
5
M95KG522R0
5
Antibodies, Monoclonal, Humanized
4
Azetidines
4
Benzyl Compounds
4
Economic evaluation
4
Fingolimod
4
RR6P8L282I
4
Relapsing multiple sclerosis
4
Secondary progressive multiple sclerosis
4
cost-effectiveness
4
ocrelizumab
4
siponimod
4
3A189DH42V
3
Comparative Study
3
Cost-effectiveness
3
Disease-modifying therapy
3
Health economics
3
Meta-analysis
3
Prevalence
3
Review
3
Systematic review
3
disease-modifying therapies
3
secondary progressive multiple sclerosis
3
77238-31-4
2
A10SJL62JY
2
Budget Impact
2
Canada
2
Dimethyl Fumarate
2
FO2303MNI2
2
I11
2
Immunologic Factors
2
Indirect treatment comparison
2
Interferon beta-1a
2
Interferon-beta
2
mehr ...